Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Anna Ulldemolins(Universitat Autònoma de Barcelona), Simó Schwartz(CIBBIM-Nanomedicine), Diana Rafael(University of Lisbon), Petra Gener(CIBBIM-Nanomedicine), Fernanda Andrade(Universidade do Porto), Ibane Abasolo(Unknown), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca)
Cited by 85
Related Papers
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases
|Advanced Drug Delivery Reviews|2013|237
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181
Bacterial inclusion bodies: making gold from waste
|Trends in biotechnology|2011|173
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
|Microbial Cell Factories|2015|147
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells
|Nanomedicine Nanotechnology Biology and Medicine|2015|85